Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
4 hedge funds and large institutions have $278K invested in Meihua International Medical Technologies in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
292% more capital invested
Capital invested by funds: $71K → $278K (+$207K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$250K |
| 2 |
JP Morgan Chase
New York
|
+$10.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.41K |
| 4 |
Citigroup
New York
|
+$1.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$62K |
MHUA Hedge Fund Activity: Q4 2022 in Review
4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q4 2022, worth a combined $278K — up 292% from $71K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MHUA positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $250K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $62K sold.
- 4 institutional investors held Meihua International Medical Technologies (MHUA) as of Q4 2022, up from 2 in Q3 2022.
- Funds reported $278K of Meihua International Medical Technologies stock for Q4 2022, up 292% quarter-over-quarter.
- 3 funds opened new Meihua International Medical Technologies positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest Meihua International Medical Technologies buyer in Q4 2022 was Invesco, an estimated $250K added.
- The largest Meihua International Medical Technologies seller in Q4 2022 was Susquehanna International Group, an estimated $62K sold.
Based on aggregated 13F filings for Q4 2022.